secwatch.observer — SEC 8-K summary
======================================

Issuer:     CorMedix Inc. (CRMD)
CIK:        0001410098
Form:       8-K
Filed at:   2026-06-08T12:45:18+00:00
Accession:  0001213900-26-066061
Event type: litigation
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Federal Circuit upholds CorMedix's MINOCIN patents; Nexus generic barred from market
--------------------------------------------------------------------------------

- Federal Circuit affirmed district court: Nexus generic minocycline infringes two CorMedix patents, invalidity rejected.
- Permanent injunction upheld barring Nexus from marketing generic before patent expiration.
- Patents are FDA Orange Book listed covering MINOCIN for Injection, used for serious infections.
- CEO Joseph Todisco: ruling validates strength of MINOCIN IP portfolio and protects innovation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410098/000121390026066061/0001213900-26-066061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410098/000121390026066061/ea0293895-8k_cormedix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-066061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer